OCC Q1 2026 Earnings Net Loss of 005 Per Share Stock Climbs 788 Indaptus Therapeutics Q4 2025 Earnings EPS Miss Amid Continued RD Investment OPTU Q1 2026 Earnings Massive EPS Miss as Company Reports Unexpectedly Wide Loss PDEX Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction MSDL Q1 2026 Earnings Narrow EPS Beat in a Challenging Rate Environment SCZM Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Edges Higher